Jul
17
2020
A framework allowing a more sensible approach to health data collection
In our previous blog we outlined the pressure on hospital margins and the entire hospital business model as a direct result of Covid-19. One solution is the sale by...
Jul
16
2020
AZN's market-cap breached the £100bn break-out line thanks to the Covid-crisis, the British pharma giant promised that during the pandemic it won’t make profit on the vaccine, but maybe it should.
AZN.L relative 12m share price performance (lighter line) vs....
Jul
15
2020
Covid-19 has given us a glimpse into the long and costly process of drug development. While health experts are speculating on a covid-19 vaccine by 2021, the reality is that the drug development process can take about 10-15 years...
Jul
13
2020
At the moment there isn't any underlying evidence as to whether or not a face mask could kill the Covid-19 virus using electricity as indicated in the story on 5th June 2020 in Popular Mechanics (which we summarise below),...
Jul
10
2020
The Food and Drug Administration (FDA - US healthcare regulator) will endeavour to review many drugs applications in the next year in relation to coronavirus, but concerns are emerging that if the FDA follows its old ways it will...
Jun
29
2020
The nutraceutical market has seen an uptick in demand despite the backdrop of widespread declines in global markets during March (though now largely rebounded) and a bearish outlook for global GDP. The bullish outlook for nutraceuticals is driven by...
Jun
26
2020
Drug makers typically raise prices at the beginning of the year and this year is no different. Prices on 457 brand name drugs are due to increase this year by an average of 5.1%. (GoodRx). About 102 drug manufacturers,...
Mar
23
2020
The world’s fastest supercomputer has quickly identified an initial 8,000 possible chemicals that might, in more time, lead to one that could stop coronavirus and is safe to use on humans, so there is hope from several areas (both...
